Alpharetta, GA, United States of America

Phillip A Schorr

This inventor holds 29 USPTO granted patents and 5 published patent applications, plus 10 CIPO patents and 16 EPO patents, primarily in Pain Management Technologies. Top assignees: Avent, Inc., Kimberly-Clark Worldwide, Inc., O&m Halyard, Inc.. Active years: 2005-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Phillip A Schorr. Retrieved from https://idiyas.com/inventor/phillip-a-schorr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 5)

% Patents Active = 82.8

CIPO Patents = 10 (Patent Applications = 1)

EPO Patents = 16 (Patent Applications = 11)

Average Co-Inventor Count = 4.5

ph-index = 11

Forward Citations = 408(Granted Patents)

Location History:

Atlanta, GA (US) (2005 - 2019)
Cumming, GA (US) (2014 - 2023)
Alpharetta, GA (US) (2020 - 2023)

Company Filing History:

Kimberly-Clark Worldwide, Inc.

Years Active: 2005-2025

Loading Chart...

Areas of Expertise:

Nerve Modulation

Electrical Stimulation

Chronic Pain Treatment

EMG Guidance

Percutaneous Lead Placement

Cooled RF Probes

Traumatic Wound Dressing

Germicidal Face Mask

Thermal Coverings

Breathable Film

Anti-Wicking Workwear

High-Speed Inkjet Printing

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12377272 - Device and method to selectively and reversibly modulate a nervous system structure to inhibit pain (2025-08-05),

2. 12343069 - EMG guidance for probe placement, nearby tissue preservation, and lesion confirmation (2025-07-01),

3. 11826154 - Method and system for identification of source of chronic pain and treatment (2023-11-28),

4. 11623091 - Portable electrical stimulation system and method (2023-04-11),

5. 11464971 - Selective nerve fiber block method and system (2022-10-11),

6. 11446498 - Device and method to selectively and reversibly modulate a nervous system structure to inhibit pain (2022-09-20),

7. 11432870 - Cooled RF probes (2022-09-06),

8. 11305115 - Percutaneous lead placement assembly (2022-04-19),

9. 11202909 - Device and method to selectively and reversibly modulate a nervous system structure to inhibit pain (2021-12-21),

10. 11091281 - Film to film packaging solution for sterilized nonwoven fabric products (2021-08-17),

11. 10940312 - Treatment kit to percutaneously block painful sensations hosted by a peripheral nerve (2021-03-09),

12. 10828491 - Device and method to selectively and reversibly modulate a nervous system structure to inhibit pain (2020-11-10),

13. 10792496 - System and method to percutaneously block painful sensations (2020-10-06),

14. 10780270 - System and method to percutaneously block painful sensations (2020-09-22),

15. 10512413 - Method and system for identification of source of chronic pain and treatment (2019-12-24),

Title: Innovations and Contributions of Phillip A. Schorr

Introduction

Phillip A. Schorr, based in Alpharetta, GA, is a prolific inventor with an impressive portfolio of 27 patents to his name. His work primarily focuses on methods and systems designed to identify and treat chronic pain, showcasing his commitment to advancing medical technology and improving patient outcomes.

Latest Patents

Among his recent patents, the “Method and system for identification of source of chronic pain and treatment” stands out. This innovative method involves identifying and treating neural pathways associated with chronic pain through nerve stimulation and brain wave monitoring. The process includes the strategic positioning of a probe to stimulate a target nerve suspected to be a pain source, followed by delivering nerve stimulation to elicit a brain response. This comprehensive approach is not only aimed at identifying the pain source effectively but also includes additional stimulations to confirm the correct pathway and provide effective treatment.

Another notable patent is the “Portable electrical stimulation system and method.” This invention presents a user-friendly system that allows for the modulation of targeted nerves to block pain conduction. Designed for portability, it enables patients to receive therapy continuously while remaining mobile. The system effectively delivers high-frequency electrical stimulation at therapeutic levels, ensuring comfort and management for users during extended use.

Career Highlights

Phillip has made significant contributions during his tenure at renowned companies such as Avent, Inc. and Kimberly-Clark Worldwide, Inc. His work in these organizations has been instrumental in shaping innovative solutions that address complex health challenges.

Collaborations

Throughout his career, Phillip has collaborated with several notable colleagues, including Eric Anthony Schepis and Ryan Caldwell. These partnerships have fostered creativity and shared expertise, further advancing their collective impact on the field of pain management technology.

Conclusion

Phillip A. Schorr's dedication to innovation and his impressive array of patents exemplify his role as a leading inventor in the field of medical technology. His contributions are paving the way for new treatments that enhance the quality of life for individuals suffering from chronic pain. Through continued collaboration and innovation, Phillip's work sets a strong foundation for future advancements in pain management solutions.

Profile summary based on public USPTO records.